Alzheimer’s disease remains one of medicine’s toughest challenges, affecting millions and costing trillions of dollars annually. If someone you know has Alzheimer’s, you’ve likely experienced ...

Two already-approved medications may help overturn brain changes caused by Alzheimer's disease, according to a recent study ...

With the FDA approval of its zongertinib in certain non-small cell lung cancer (NSCLC) patients, 175-year-old Boehringer ...

A combo of cancer drugs letrozole and irinotecan has been identified — via a complex AI-driven study — to reverse memory ...

Most people ‘have no idea’ that these 4 common medications can increase their risk of skin cancer By Tracy Swartz Published Feb. 27, 2025, 6:00 a.m. ET ...

Ibrance is one of the biggest-selling drugs in a revolution that has made new treatments available to American cancer patients faster than ever before. Prodded by legislation backed by drugmakers ...

Lower drug prices mean lower out-of-pocket expenses, fewer treatment delays and fewer financial trade-offs between health and household needs. For someone with cancer, that can be life-changing.

In 2025, over 2 million new cancer cases are expected in the U.S., with more than 618,000 deaths—about 1,700 per day—according to the American Cancer Society.

A newly expanded prostate cancer drug could bring new hope to patients with a common form of the disease. Novartis, a Switzerland-based pharmaceutical company, announced on March 28 that the U.S ...